Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Swedish Orphan Biovitrum AB (publ) | 9,576 | net | 22 Aug 2018 | tx 1+9,576 |
| A1M Pharma | 6,000 | net | 22 Jul 2024 | tx 2+6,000 |
| Camurus AB | 4,250 | net | 18 Feb 2026 | tx 8+4,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Feb 2026 | PURCHASE | Camurus AB | 300 | 515.00 SEK | |
| 01 Dec 2025 | PURCHASE | Camurus AB | 200 | 620.00 SEK | |
| 04 Jun 2025 | PURCHASE | Camurus AB | 500 | 648.00 SEK | |
| 22 Jul 2024 | PURCHASE | A1M Pharma | 3,000 | 29.91 SEK | |
| 15 Sept 2023 | PURCHASE | Camurus AB | 650 | 291.15 SEK | first after silence |
| 23 Nov 2021 | PURCHASE | Camurus AB | 1,500 | 164.99 SEK | |
| 23 Jul 2021 | PURCHASE | Camurus AB | 425 | 186.40 SEK | |
| 20 Jul 2021 | PURCHASE | Camurus AB | 100 | 172.40 SEK | |
| 14 Dec 2020 | PURCHASE | Camurus AB | 575 | 172.66 SEK | |
| 22 Aug 2018 | GRANT_AWARD | Swedish Orphan Biovitrum AB (publ) | 9,576 | 266.90 SEK |
1 purchase reported after at least 12 months of silence — most recent on 15 Sept 2023.